News Daily News High-Sensitivity Troponin Tests Might Aid in Primary Prevention Yael L. Maxwell April 16, 2025
News Daily News High BMI Before Pregnancy Tied to Greater CVD Risk Later in Life L.A. McKeown April 14, 2025
News Daily News COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year Todd Neale April 11, 2025
News Conference News ACC 2025 ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a) L.A. McKeown April 10, 2025
News Conference News EHRA 2025 SWISS-APERO at 3 Years: Hints of Differences Between Amulet, Watchman Emerge Todd Neale April 09, 2025
News Conference News EHRA 2025 Post-TAVI Pacemaker Tied to Poorer Long-term Outcomes Todd Neale April 08, 2025
News Conference News ACC 2025 RACER: No Change in Cardiac Arrests During Marathons, but Survival Is Up Michael O'Riordan April 08, 2025
News Conference News ACC 2025 AI Shows Promise in Detecting Type 1 MI and Need for Revascularization Yael L. Maxwell April 07, 2025
News Conference News ACC 2025 DETECT-AS: Alert System Increases AV Replacement in Eligible Patients Michael O'Riordan April 04, 2025
News Conference News ACC 2025 FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints L.A. McKeown April 03, 2025
News Conference News ACC 2025 Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP Michael O'Riordan April 01, 2025
News Conference News ACC 2025 PCI Rebounds at 5 Years to Mostly Match CABG: Final FAME 3 Data Caitlin E. Cox March 31, 2025
News Conference News ACC 2025 By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE Michael O'Riordan March 31, 2025
News Conference News ACC 2025 Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years L.A. McKeown March 30, 2025
News Conference News ACC 2025 Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI Caitlin E. Cox March 30, 2025
News Conference News ACC 2025 Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection Michael O'Riordan March 30, 2025
News Conference News ACC 2025 SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes Michael O'Riordan March 29, 2025